Compare GRFS & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | ACT |
|---|---|---|
| Founded | 1940 | 1981 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.6B |
| IPO Year | N/A | 2021 |
| Metric | GRFS | ACT |
|---|---|---|
| Price | $8.93 | $42.58 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $10.15 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 446.1K | 309.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | 1.54% | ★ 1.98% |
| EPS Growth | N/A | ★ 6.33 |
| EPS | N/A | ★ 3.30 |
| Revenue | N/A | ★ $1,201,774,000.00 |
| Revenue This Year | $5.47 | $4.14 |
| Revenue Next Year | $4.92 | $2.41 |
| P/E Ratio | $18.67 | ★ $12.83 |
| Revenue Growth | N/A | ★ 4.17 |
| 52 Week Low | $6.19 | $31.28 |
| 52 Week High | $11.14 | $44.80 |
| Indicator | GRFS | ACT |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 57.79 |
| Support Level | $8.66 | $37.06 |
| Resistance Level | $9.11 | $44.80 |
| Average True Range (ATR) | 0.29 | 1.04 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 42.28 | 49.76 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.